| Secondary |
| Cognitive Disorder |
10.2% |
| Contraception |
10.2% |
| Drug Exposure During Pregnancy |
10.2% |
| Oral Contraception |
8.5% |
| Affective Disorder |
6.8% |
| Bipolar Disorder |
6.8% |
| Depression |
5.1% |
| Fatigue |
5.1% |
| Headache |
5.1% |
| Migraine |
5.1% |
| Multiple Sclerosis |
5.1% |
| Ovarian Cyst |
5.1% |
| Pelvic Pain |
5.1% |
| Vulvovaginal Candidiasis |
3.4% |
| Asthma |
1.7% |
| Blister |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Lichen Planus |
1.7% |
| Product Used For Unknown Indication |
1.7% |
|
| Drug Eruption |
25.0% |
| Unintended Pregnancy |
18.8% |
| Drug Interaction |
6.3% |
| Erythema |
6.3% |
| Menstruation Irregular |
6.3% |
| Oropharyngeal Pain |
6.3% |
| Ovarian Cyst |
6.3% |
| Pulmonary Embolism |
6.3% |
| Skin Striae |
6.3% |
| Syncope |
6.3% |
| Umbilical Artery Hypoplasia |
6.3% |
|
| Concomitant |
| Contraception |
11.3% |
| Product Used For Unknown Indication |
11.3% |
| Bipolar Disorder |
8.2% |
| Drug Use For Unknown Indication |
8.2% |
| Depression |
7.5% |
| Multiple Sclerosis |
6.3% |
| Acne |
5.0% |
| Epilepsy |
5.0% |
| Crohn's Disease |
4.4% |
| Migraine |
4.4% |
| Oral Contraception |
4.4% |
| Post Coital Contraception |
3.8% |
| Anxiety |
3.1% |
| Colitis Ulcerative |
3.1% |
| Convulsion |
3.1% |
| Neuralgia |
3.1% |
| Back Pain |
1.9% |
| Complex Partial Seizures |
1.9% |
| Dysmenorrhoea |
1.9% |
| Fabry's Disease |
1.9% |
|
| Weight Increased |
17.1% |
| Unintended Pregnancy |
11.4% |
| Menstruation Irregular |
7.1% |
| Pulmonary Embolism |
7.1% |
| Pyrexia |
5.7% |
| Constipation |
4.3% |
| Nausea |
4.3% |
| Pancreatitis |
4.3% |
| Rash |
4.3% |
| Sinus Tachycardia |
4.3% |
| Vomiting |
4.3% |
| Alopecia |
2.9% |
| Back Pain |
2.9% |
| Drug Ineffective |
2.9% |
| Hallucination |
2.9% |
| Hypersensitivity |
2.9% |
| Nasopharyngitis |
2.9% |
| Pain In Extremity |
2.9% |
| Phlebitis |
2.9% |
| Pregnancy |
2.9% |
|
| Interacting |
| Depression |
40.0% |
| Ankylosing Spondylitis |
20.0% |
| Contraception |
20.0% |
| Drug Use For Unknown Indication |
20.0% |
|
| Drug Interaction |
50.0% |
| Pregnancy |
50.0% |
|
